Barometer Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Barometer Capital Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-50,700	Closed	-$3.16M	–	162
2018 Q4	$3.16M	Sell	50,700 -27,000	-35%	-$1.82M	0.64%	57
2018 Q3	$5.71M	Buy	+77,700	New	+$5.58M	0.44%	92
2015 Q2	–	Sell	-11,000	Closed	-$840K	–	185
2015 Q1	$840K	Buy	11,000 +3,000	+38%	+$220K	0.06%	105
2014 Q4	$532K	Sell	8,000 -15,200	-66%	-$1.01M	0.05%	114
2014 Q3	$1.48M	Buy	+23,200	New	+$1.43M	0.12%	61
2014 Q2	–	Sell	-39,800	Closed	-$2.25M	–	129
2014 Q1	$2.25M	Buy	39,800 +24,700	+164%	+$1.4M	0.49%	31
2013 Q4	$807K	Buy	+15,100	New	+$756K	0.2%	70

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Barometer Capital Management's PJP Position: Q1 2019 in Review

Barometer Capital Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2019, closing a stake of 50,700 shares — an estimated $3.16M sold.

Barometer Capital Management first reported a position in PJP in Q4 2013 and held it in 7 quarters. The position peaked at $5.71M in Q3 2018. 95 funds tracked by Wall St. Rank hold PJP as of Q1 2019.

Barometer Capital Management reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
Barometer Capital Management sold 50,700 Invesco Pharmaceuticals ETF shares in Q1 2019, an estimated $3.16M.
Barometer Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2013 and held it in 7 quarters.
Barometer Capital Management's Invesco Pharmaceuticals ETF position peaked at $5.71M in Q3 2018.
95 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2019.

Based on Barometer Capital Management's 13F filing for Q1 2019, filed 18 Apr 2019.